AGIO
STRONGAGIOS PHARMACEUTICALS, INC.
CIK: 0001439222
Last activity: 4 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Goff Brian
Chief Executive Officer
|
0 | 5 | -$1.03M |
157,466 shares
$4.56M
|
|
Milanova Tsveta
Chief Commercial Officer
|
0 | 4 | -$240K |
38,778 shares
$1.12M
|
|
Burns James William
Chief Legal Officer
|
0 | 5 | -$231K |
38,516 shares
$1.12M
|
|
Jones Cecilia
Chief Financial Officer
|
0 | 5 | -$225K |
42,785 shares
$1.24M
|
|
Washburn Theodore James Jr.
Principal Accounting Officer
|
0 | 4 | -$217K |
868 shares
$25K
|
|
Gheuens Sarah
Chief Medical Officer
|
0 | 4 | -$197K |
71,593 shares
$2.07M
|
|
Viswanadhan Krishnan
Chief Corp Dev & Strategy
|
0 | 1 | -$82K |
5,141 shares
$143K
|
Recent Transactions
2,959 shares @ $27.80
$82K
Mar 5, 2026
5,272 shares @ $28.88
$152K
Mar 3, 2026
8,267 shares @ $28.96
$239K
Mar 2, 2026
5,918 shares @ $28.96
$171K
Mar 2, 2026
3,870 shares @ $28.96
$112K
Mar 2, 2026
1,681 shares @ $28.96
$49K
Mar 2, 2026
1,681 shares @ $28.96
$49K
Mar 2, 2026
1,681 shares @ $28.96
$49K
Mar 2, 2026
1,681 shares @ $28.96
$49K
Mar 2, 2026
1,573 shares @ $28.96
$46K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,187 shares @ $28.96
$34K
Mar 2, 2026
1,163 shares @ $28.96
$34K
Mar 2, 2026
798 shares @ $28.96
$23K
Mar 2, 2026
727 shares @ $28.96
$21K
Mar 2, 2026
698 shares @ $28.96
$20K
Mar 2, 2026
594 shares @ $28.96
$17K
Mar 2, 2026
2,872 shares @ $27.02
$78K
Jan 5, 2026
12,473 shares @ $27.09
$338K
Dec 30, 2025
6,230 shares @ $27.09
$169K
Dec 30, 2025
2,932 shares @ $27.09
$79K
Dec 30, 2025
2,932 shares @ $27.09
$79K
Dec 30, 2025
2,932 shares @ $27.09
$79K
Dec 30, 2025
2,932 shares @ $27.09
$79K
Dec 30, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.